SEC Tracker
Get the app
Person · CIK 1323113

Daniel N Swisher JR

Director at Corcept Therapeutics and Cerus

Earlier: Protagonist Therapeutics, Jazz Pharmaceuticals and Sunesis Pharmaceuticals

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$4.3M
Noticed on Form 144$2.6M
Bought on Form 4$180K
Companies5

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

CompanySecurityHeldShares or unitsAs of
Corcept Therapeutics CORTStock Option (right to buy)
exercise $59.69, expires May 21, 2036, into Common Stock
Directly12,500May 21, 2026 · Filing · EDGAR
Cerus CERSCommon StockDirectly207,045Jun 3, 2025 · Filing · EDGAR
Protagonist TherapeuticsStock Option (right to buy)
exercise $14.21, expires Oct 26, 2033, into Common Stock
Directly45,000Oct 26, 2023 · Filing · EDGAR
Jazz PharmaceuticalsOrdinary SharesDirectly55,014Mar 5, 2023 · Filing · EDGAR
Jazz PharmaceuticalsNon-Qualified Stock Option (right to buy)
exercise $113.10, expires Feb 26, 2030, into Ordinary Shares
Directly39,114Feb 27, 2020 · Filing · EDGAR
Jazz PharmaceuticalsIncentive Stock Option (right to buy)
exercise $113.10, expires Feb 26, 2030, into Ordinary Shares
Directly886Feb 27, 2020 · Filing · EDGAR
Sunesis PharmaceuticalsCommon StockDirectly128,017Feb 28, 2024 · Filing · EDGAR
Sunesis PharmaceuticalsCommmon StockSee footnote.199,736Feb 29, 2016 · Filing · EDGAR
Sunesis PharmaceuticalsCommon StockSee footnote174,336Jul 24, 2015 · Filing · EDGAR
Sunesis PharmaceuticalsCommon StockSee footnotes127,176Nov 28, 2011 · Filing · EDGAR
Sunesis PharmaceuticalsCommon StockSee footnote.33,289Nov 30, 2016 · Filing · EDGAR
Sunesis PharmaceuticalsEmployee Stock Option(right to buy)
exercise $2.62, expires Jul 10, 2027, into Common Stock
Directly240,177Jul 10, 2017 · Filing · EDGAR
Sunesis PharmaceuticalsEmployee Stock Option (right to buy)
exercise $2.62, expires Jul 10, 2027, into Common Stock
Directly17,582Jul 10, 2017 · Filing · EDGAR

Sold and noticed by quarter

Daniel N Swisher JR: dollars sold on Form 4 and noticed on Form 144 per quarter, Q1 2021 to Q4 2026$475K$0Q1 2021: notice not machine-readableQ1 2021: $221K sold on Form 4Q2 2021: notice not machine-readableQ2 2021: $371K sold on Form 4Q3 2021: notice not machine-readableQ3 2021: $243K sold on Form 4Q4 2021: $0 noticed on Form 144Q4 2021: $0 sold on Form 4Q1 2022: $0 noticed on Form 144Q1 2022: $0 sold on Form 4Q2 2022: $0 noticed on Form 144Q2 2022: $0 sold on Form 4Q3 2022: notice not machine-readableQ3 2022: $436K sold on Form 4Q4 2022: notice not machine-readableQ4 2022: $49K sold on Form 4Q1 2023: $0 noticed on Form 144Q1 2023: $0 sold on Form 4Q2 2023: $0 noticed on Form 144Q2 2023: $0 sold on Form 4Q2 2023: $10K boughtQ3 2023: $209K noticed on Form 144Q3 2023: $209K sold on Form 4Q4 2023: $178K noticed on Form 144Q4 2023: $178K sold on Form 4Q1 2024: $149K noticed on Form 144Q1 2024: $149K sold on Form 4Q2 2024: $173K noticed on Form 144Q2 2024: $173K sold on Form 4Q2 2024: $5K boughtQ3 2024: $78K noticed on Form 144Q3 2024: $78K sold on Form 4Q4 2024: $263K noticed on Form 144Q4 2024: $263K sold on Form 4Q1 2025: $379K noticed on Form 144Q1 2025: $379K sold on Form 4Q2 2025: $468K noticed on Form 144Q2 2025: $468K sold on Form 4Q3 2025: $475K noticed on Form 144Q3 2025: $475K sold on Form 4Q4 2025: $193K noticed on Form 144Q4 2025: $193K sold on Form 4Q1 2026: $0 noticed on Form 144Q1 2026: $0 sold on Form 4Q2 2026: $0 noticed on Form 144Q2 2026: $0 sold on Form 4Q3 2026: $0 noticed on Form 144Q3 2026: $0 sold on Form 4Q4 2026: $0 noticed on Form 144Q4 2026: $0 sold on Form 4Q1 2021Q2 2022Q3 2023Q4 2024Q1 2026

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table
QuarterSold (Form 4)Noticed (Form 144)Bought (Form 4)
Q4 2025$193K$193K—
Q3 2025$475K$475K—
Q2 2025$468K$468K—
Q1 2025$379K$379K—
Q4 2024$263K$263K—
Q3 2024$78K$78K—
Q2 2024$173K$173K$5K
Q1 2024$149K$149K—
Q4 2023$178K$178K—
Q3 2023$209K$209K—
Q2 2023——$10K
Q4 2022$49KNot machine-readable—
Q3 2022$436KNot machine-readable—
Q3 2021$243KNot machine-readable—
Q2 2021$371KNot machine-readable—
Q1 2021$221KNot machine-readable—
Q4 2020$151KNot machine-readable—
Q3 2020$82KNot machine-readable—
Q2 2020$81KNot machine-readable—
Q1 2020——$4K
Q3 2015$44KNot machine-readable$51K
Q3 2014$40KNot machine-readable—
Q4 2011——$5K
Q3 2011——$10K
Q1 2007——$21K
Q4 2006——$75K

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice dateNoticedPlanned saleOutcomeLinks
Corcept Therapeutics CORT · Fidelity Brokerage Services · 10b5-1 plan adopted Aug 1, 2024 · 13 notices
Oct 10, 20252,200 · ~$193KOct 10, 2025Sold as noticed Sold 2,200 at $87.54 on Oct 10 · $193K Form 4Filing · EDGAR
Sep 10, 20252,200 · ~$159KSep 10, 2025Sold as noticed Sold 2,200 at $72.45 on Sep 10 · $159K Form 4Filing · EDGAR
Aug 11, 20252,200 · ~$159KAug 11, 2025Sold as noticed Sold 2,200 at $72.30 on Aug 11 · $159K Form 4Filing · EDGAR
Jul 10, 20252,200 · ~$156KJul 10, 2025Sold as noticed Sold 2,200 at $71.08 on Jul 10 · $156K Form 4Filing · EDGAR
Jun 10, 20252,200 · ~$155KJun 10, 2025Sold as noticed Sold 2,200 at $70.61 on Jun 10 · $155K Form 4Filing · EDGAR
May 12, 2025400 · ~$29KMay 12, 2025Sold as noticed Sold 400 at $71.55 on May 12 · $29K Form 4Filing · EDGAR
May 12, 20251,800 · ~$130KMay 12, 2025Sold as noticed Sold 1,800 at $72.17 on May 12 · $130K Form 4Filing · EDGAR
Apr 10, 20252,200 · ~$154KApr 10, 2025Sold as noticed Sold 2,200 at $70.22 on Apr 10 · $154K Form 4Filing · EDGAR
Mar 10, 20252,200 · ~$118KMar 10, 2025Sold as noticed Sold 2,200 at $53.60 on Mar 10 · $118K Form 4Filing · EDGAR
Feb 10, 20252,200 · ~$150KFeb 10, 2025Sold as noticed Sold 2,200 at $68.08 on Feb 10 · $150K Form 4Filing · EDGAR
Jan 10, 20252,200 · ~$111KJan 10, 2025Sold as noticed Sold 2,200 at $50.54 on Jan 10 · $111K Form 4Filing · EDGAR
Dec 10, 20242,200 · ~$131KDec 10, 2024Sold as noticed Sold 2,200 at $59.46 on Dec 10 · $131K Form 4Filing · EDGAR
Nov 12, 20242,200 · ~$132KNov 11, 2024Sold as noticed Sold 2,200 at $59.88 on Nov 11 · $132K Form 4Filing · EDGAR
Corcept Therapeutics CORT · Fidelity Brokerage Services · 10b5-1 plan adopted May 8, 2023 · 14 notices
Aug 1, 2024150 · ~$6KAug 1, 2024Sold as noticed Sold 150 at $38.50 on Aug 1 · $6K Form 4Filing · EDGAR
Jul 1, 20242,200 · ~$72KJul 1, 2024Sold as noticed Sold 2,200 at $32.81 on Jul 1 · $72K Form 4Filing · EDGAR
Jun 3, 20242,200 · ~$66KJun 3, 2024Sold as noticed Sold 2,200 at $30.21 on Jun 3 · $66K Form 4Filing · EDGAR
May 1, 20242,200 · ~$51KMay 1, 2024Sold as noticed Sold 2,200 at $23.09 on May 1 · $51K Form 4Filing · EDGAR
Apr 1, 20242,200 · ~$56KApr 1, 2024Sold as noticed Sold 2,200 at $25.30 on Apr 1 · $56K Form 4Filing · EDGAR
Mar 1, 20242,200 · ~$52KMar 1, 2024Sold as noticed Sold 2,200 at $23.59 on Mar 1 · $52K Form 4Filing · EDGAR
Feb 1, 20242,200 · ~$48KFeb 1, 2024Sold as noticed Sold 2,200 at $22.00 on Feb 1 · $48K Form 4Filing · EDGAR
Jan 2, 20242,200 · ~$49KJan 2, 2024Sold as noticed Sold 2,200 at $22.11 on Jan 2 · $49K Form 4Filing · EDGAR
Dec 1, 20232,200 · ~$56KDec 1, 2023Sold as noticed Sold 2,200 at $25.47 on Dec 1 · $56K Form 4Filing · EDGAR
Nov 1, 20232,200 · ~$62KNov 1, 2023Sold as noticed Sold 2,200 at $27.96 on Nov 1 · $62K Form 4Filing · EDGAR
Oct 2, 20232,200 · ~$60KOct 2, 2023Sold as noticed Sold 2,200 at $27.32 on Oct 2 · $60K Form 4Filing · EDGAR
Sep 5, 20232,200 · ~$72KSep 5, 2023Sold as noticed Sold 2,200 at $32.90 on Sep 5 · $72K Form 4Filing · EDGAR
Sep 1, 20231,550 · ~$51KSep 1, 2023Sold as noticed Sold 1,550 at $32.73 on Sep 1 · $51K Form 4Filing · EDGAR
Aug 7, 20232,850 · ~$86KAug 7, 2023Sold as noticed Sold 2,850 in 2 sales, Aug 7 to Aug 7 · $86K Form 4Filing · EDGAR
Sales without a matching Form 144 · 16 sales
No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
———Notice not machine-readable Cerus (CERS): Sold 12,500 at $3.91 on Nov 10, 2022 · $49KFiling · EDGAR
———Notice not machine-readable Corcept Therapeutics (CORT): Sold 15,385 at $28.32 on Aug 8, 2022 · $436KFiling · EDGAR
———Notice not machine-readable Corcept Therapeutics (CORT): Sold 7,500 at $21.70 on Sep 2, 2021 · $163K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable Cerus (CERS): Sold 12,877 at $6.25 on Aug 4, 2021 · $80K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable Corcept Therapeutics (CORT): Sold 7,500 at $21.48 on Jun 2, 2021 · $161K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable Cerus (CERS): Sold 5,000 at $5.75 on May 18, 2021 · $29K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable Corcept Therapeutics (CORT): Sold 7,500 at $24.14 on Apr 5, 2021 · $181K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable Cerus (CERS): Sold 10,000 at $7.78 on Feb 16, 2021 · $78K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable Corcept Therapeutics (CORT): Sold 5,000 at $28.74 on Jan 19, 2021 · $144K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable Cerus (CERS): Sold 10,000 at $6.25 on Nov 17, 2020 · $63KFiling · EDGAR
———Notice not machine-readable Corcept Therapeutics (CORT): Sold 5,000 at $17.66 on Oct 19, 2020 · $88K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable Corcept Therapeutics (CORT): Sold 5,000 at $16.48 on Jul 17, 2020 · $82K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable Corcept Therapeutics (CORT): Sold 5,000 at $16.10 on May 22, 2020 · $81K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable Sunesis Pharmaceuticals: Sold 4,238 at $3.46 on Jul 24, 2015 · $15KFiling · EDGAR
———Notice not machine-readable Sunesis Pharmaceuticals: Sold 8,477 at $3.46 on Jul 24, 2015 · $29KFiling · EDGAR
———Notice not machine-readable Sunesis Pharmaceuticals: Sold 5,000 at $8.00 on Aug 27, 2014 · $40K (10b5-1 plan)Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Corcept Therapeutics CORT Director · filings 2015 to 2026 · sold $3.9M · $2.6M noticed on Form 144

DateTransactionSharesPriceValueHeld afterSource
May 21, 2026Grant or award from the company
Stock Option (right to buy)
+12,50012,500 directFiling · EDGAR
Oct 10, 2025Option or RSU exercised or converted+2,200$14.08$31K2,200 directFiling · EDGAR
Oct 10, 2025Sale under a 10b5-1 plan−2,200$87.54$193K0 directFiling · EDGAR
Oct 10, 2025Option or RSU exercised or converted
Stock option (right to buy)
−2,2001,100 directFiling · EDGAR
Sep 10, 2025Option or RSU exercised or converted+2,200$14.08$31K2,200 directFiling · EDGAR
Sep 10, 2025Sale under a 10b5-1 plan−2,200$72.45$159K0 directFiling · EDGAR
Sep 10, 2025Option or RSU exercised or converted
Stock option (right to buy)
−2,2003,300 directFiling · EDGAR
Aug 11, 2025Option or RSU exercised or converted+2,200$14.08$31K2,200 directFiling · EDGAR
Aug 11, 2025Sale under a 10b5-1 plan−2,200$72.30$159K0 directFiling · EDGAR
Aug 11, 2025Option or RSU exercised or converted
Stock option (right to buy)
−2,2005,500 directFiling · EDGAR
Jul 10, 2025Option or RSU exercised or converted+2,200$14.08$31K2,200 directFiling · EDGAR
Jul 10, 2025Sale under a 10b5-1 plan−2,200$71.08$156K0 directFiling · EDGAR
Jul 10, 2025Option or RSU exercised or converted
Stock option (right to buy)
−2,2007,700 directFiling · EDGAR
Jun 10, 2025Option or RSU exercised or converted+2,200$14.08$31K2,200 directFiling · EDGAR
Jun 10, 2025Sale under a 10b5-1 plan−2,200$70.61$155K0 directFiling · EDGAR
Jun 10, 2025Option or RSU exercised or converted
Stock option (right to buy)
−2,2009,900 directFiling · EDGAR
Jun 10, 2025Grant or award from the company
Stock option (right to buy)
+15,00015,000 directFiling · EDGAR
May 12, 2025Option or RSU exercised or converted+1,800$12.13$22K1,800 directFiling · EDGAR
May 12, 2025Option or RSU exercised or converted+400$14.08$6K2,200 directFiling · EDGAR
May 12, 2025Sale under a 10b5-1 plan−1,800$72.17$130K400 directFiling · EDGAR
May 12, 2025Sale under a 10b5-1 plan−400$71.55$29K0 directFiling · EDGAR
May 12, 2025Option or RSU exercised or converted
Stock option (right to buy)
−1,8000 directFiling · EDGAR
May 12, 2025Option or RSU exercised or converted
Stock option (right to buy)
−40012,100 directFiling · EDGAR
Apr 10, 2025Option or RSU exercised or converted+2,200$12.13$27K2,200 directFiling · EDGAR
Apr 10, 2025Sale under a 10b5-1 plan−2,200$70.22$154K0 directFiling · EDGAR
Apr 10, 2025Option or RSU exercised or converted
Stock option (right to buy)
−2,2001,800 directFiling · EDGAR
Mar 10, 2025Option or RSU exercised or converted+2,200$12.13$27K2,200 directFiling · EDGAR
Mar 10, 2025Sale under a 10b5-1 plan−2,200$53.60$118K0 directFiling · EDGAR
Mar 10, 2025Option or RSU exercised or converted
Stock option (right to buy)
−2,2004,000 directFiling · EDGAR
Feb 10, 2025Option or RSU exercised or converted+2,200$12.13$27K2,200 directFiling · EDGAR
Feb 10, 2025Sale under a 10b5-1 plan−2,200$68.08$150K0 directFiling · EDGAR
Feb 10, 2025Option or RSU exercised or converted
Stock option (right to buy)
−2,2006,200 directFiling · EDGAR
Jan 10, 2025Option or RSU exercised or converted+2,200$12.13$27K2,200 directFiling · EDGAR
Jan 10, 2025Sale under a 10b5-1 plan−2,200$50.54$111K0 directFiling · EDGAR
Jan 10, 2025Option or RSU exercised or converted
Stock option (right to buy)
−2,2008,400 directFiling · EDGAR
Dec 10, 2024Option or RSU exercised or converted+2,200$12.13$27K2,200 directFiling · EDGAR
Dec 10, 2024Sale under a 10b5-1 plan−2,200$59.46$131K0 directFiling · EDGAR
Dec 10, 2024Option or RSU exercised or converted
Stock option (right to buy)
−2,20010,600 directFiling · EDGAR
Nov 11, 2024Option or RSU exercised or converted+2,200$12.13$27K2,200 directFiling · EDGAR
Nov 11, 2024Sale under a 10b5-1 plan−2,200$59.88$132K0 directFiling · EDGAR
Nov 11, 2024Option or RSU exercised or converted
Stock option (right to buy)
−2,20012,800 directFiling · EDGAR
Aug 1, 2024Option or RSU exercised or converted+150$5.86$879150 directFiling · EDGAR
Aug 1, 2024Sale under a 10b5-1 plan−150$38.50$6K0 directFiling · EDGAR
Aug 1, 2024Option or RSU exercised or converted
Stock option (right to buy)
−1500 directFiling · EDGAR
Jul 1, 2024Option or RSU exercised or converted+2,200$5.86$13K2,200 directFiling · EDGAR
Jul 1, 2024Sale under a 10b5-1 plan−2,200$32.81$72K0 directFiling · EDGAR
Jul 1, 2024Option or RSU exercised or converted
Stock option (right to buy)
−2,200150 directFiling · EDGAR
Jun 3, 2024Option or RSU exercised or converted+2,200$5.86$13K2,200 directFiling · EDGAR
Jun 3, 2024Sale under a 10b5-1 plan−2,200$30.21$66K0 directFiling · EDGAR
Jun 3, 2024Option or RSU exercised or converted
Stock option (right to buy)
−2,2002,350 directFiling · EDGAR
May 17, 2024Grant or award from the company
Stock option (right to buy)
+30,00030,000 directFiling · EDGAR
May 1, 2024Option or RSU exercised or converted+2,200$5.86$13K2,200 directFiling · EDGAR
May 1, 2024Sale under a 10b5-1 plan−2,200$23.09$51K0 directFiling · EDGAR
May 1, 2024Option or RSU exercised or converted
Stock option (right to buy)
−2,2004,550 directFiling · EDGAR
Apr 1, 2024Option or RSU exercised or converted+2,200$5.86$13K2,200 directFiling · EDGAR
Apr 1, 2024Sale under a 10b5-1 plan−2,200$25.30$56K0 directFiling · EDGAR
Apr 1, 2024Option or RSU exercised or converted
Stock option (right to buy)
−2,2002,200 directFiling · EDGAR
Mar 1, 2024Option or RSU exercised or converted+2,200$5.86$13K2,200 directFiling · EDGAR
Mar 1, 2024Sale under a 10b5-1 plan−2,200$23.59$52K0 directFiling · EDGAR
Mar 1, 2024Option or RSU exercised or converted
Stock option (right to buy)
−2,2008,950 directFiling · EDGAR

61 earlier transactions are in the filing list below.

Cerus CERS Director · filings 2011 to 2025 · sold $298K · bought $18K

DateTransactionSharesPriceValueHeld afterSource
Jun 3, 2025Grant or award from the company+60,000207,045 directFiling · EDGAR
Jun 5, 2024Grant or award from the company+40,000$5.00$200K147,045 directFiling · EDGAR
May 9, 2024Open-market or private purchase+2,500$1.88$5K107,045 directFiling · EDGAR
Jun 7, 2023Grant or award from the company+40,000$5.00$200K104,545 directFiling · EDGAR
May 26, 2023Open-market or private purchase+5,000$1.91$10K118,808 directFiling · EDGAR
Nov 10, 2022Option or RSU exercised or converted+12,500$3.19$40K126,308 directFiling · EDGAR
Nov 10, 2022Open-market or private sale−12,500$3.91$49K113,808 directFiling · EDGAR
Nov 10, 2022Option or RSU exercised or converted
Option (Right to Buy)
−12,5000 directFiling · EDGAR
Jun 1, 2022Grant or award from the company+20,454113,808 directFiling · EDGAR
Jun 1, 2022Grant or award from the company
Option (Right to Buy)
+39,86639,866 directFiling · EDGAR
Aug 4, 2021Option or RSU exercised or converted+12,877$2.86$37K106,231 directFiling · EDGAR
Aug 4, 2021Sale under a 10b5-1 plan−12,877$6.25$80K93,354 directFiling · EDGAR
Aug 4, 2021Option or RSU exercised or converted
Option (Right to Buy)
−12,8770 directFiling · EDGAR
Jun 2, 2021Grant or award from the company+17,52593,354 directFiling · EDGAR
Jun 2, 2021Grant or award from the company
Option (Right to Buy)
+35,29535,295 directFiling · EDGAR
Jun 1, 2021Option or RSU exercised or converted+15,96175,829 directFiling · EDGAR
Jun 1, 2021Option or RSU exercised or converted
Restricted Stock Unit
−15,9610 directFiling · EDGAR
May 18, 2021Option or RSU exercised or converted+5,000$2.90$15K64,868 directFiling · EDGAR
May 18, 2021Sale under a 10b5-1 plan−5,000$5.75$29K59,868 directFiling · EDGAR
May 18, 2021Option or RSU exercised or converted
Option (Right to Buy)
−5,0000 directFiling · EDGAR
Feb 16, 2021Option or RSU exercised or converted+10,000$2.90$29K69,868 directFiling · EDGAR
Feb 16, 2021Sale under a 10b5-1 plan−10,000$7.78$78K59,868 directFiling · EDGAR
Feb 16, 2021Option or RSU exercised or converted
Option (Right to Buy)
−10,0005,000 directFiling · EDGAR
Nov 17, 2020Option or RSU exercised or converted+10,000$2.90$29K69,868 directFiling · EDGAR
Nov 17, 2020Open-market or private sale−10,000$6.25$63K59,868 directFiling · EDGAR
Nov 17, 2020Option or RSU exercised or converted
Option (Right to Buy)
−10,00015,000 directFiling · EDGAR
Jun 5, 2020Option or RSU exercised or converted+13,95859,868 directFiling · EDGAR
Jun 5, 2020Option or RSU exercised or converted
Restricted Stock Unit
−13,9580 directFiling · EDGAR
Jun 3, 2020Grant or award from the company
Option (Right to Buy)
+34,00134,001 directFiling · EDGAR
Jun 3, 2020Grant or award from the company
Restricted Stock Unit
+15,96115,961 directFiling · EDGAR
Jan 29, 2020Open-market or private purchase+1,000$4.15$4K45,910 directFiling · EDGAR
Jun 5, 2019Grant or award from the company
Option (Right to Buy)
+29,58129,581 directFiling · EDGAR
Jun 5, 2019Grant or award from the company
Restricted Stock Unit
+13,95813,958 directFiling · EDGAR
Jun 5, 2019Grant or award from the company
Option (Right to Buy)
+29,58129,581 directFiling · EDGAR
Jun 5, 2019Grant or award from the company
Restricted Stock Unit
+13,95813,958 directFiling · EDGAR
Jun 4, 2019Option or RSU exercised or converted+12,75844,910 directFiling · EDGAR
Jun 4, 2019Option or RSU exercised or converted
Restricted Stock Unit
−12,7580 directFiling · EDGAR
Jun 6, 2018Grant or award from the company
Option (Right to Buy)
+24,01424,014 directFiling · EDGAR
Jun 6, 2018Grant or award from the company
Restricted Stock Unit
+12,75812,758 directFiling · EDGAR
Jun 5, 2018Option or RSU exercised or converted+19,81632,152 directFiling · EDGAR
Jun 5, 2018Option or RSU exercised or converted
Restricted Stock Unit
−19,8160 directFiling · EDGAR
Jun 7, 2017Grant or award from the company
Option Right to Buy
+47,50747,507 directFiling · EDGAR
Jun 7, 2017Grant or award from the company
Restricted Stock Unit
+19,81619,816 directFiling · EDGAR
Jun 6, 2017Option or RSU exercised or converted+12,33612,336 directFiling · EDGAR
Jun 6, 2017Option or RSU exercised or converted
Restricted Stock Unit
−12,3660 directFiling · EDGAR
Jun 8, 2016Grant or award from the company
Option (Right to Buy)
+25,25225,252 directFiling · EDGAR
Jun 8, 2016Grant or award from the company
Restricted Stock Unit
+12,33612,336 directFiling · EDGAR
Jun 10, 2015Grant or award from the company
Option (Right to Buy)
+37,50037,500 directFiling · EDGAR
Jun 11, 2014Grant or award from the company
Option (Right to Buy)
+54,75054,750 directFiling · EDGAR
Jan 2, 2013Grant or award from the company
Option (Right to Buy)
+25,00025,000 directFiling · EDGAR
Jan 3, 2012Grant or award from the company
Option (Right to Buy)
+12,87712,877 directFiling · EDGAR
Jun 27, 2011Grant or award from the company
Option (Right to Buy)
+25,00025,000 directFiling · EDGAR

Protagonist Therapeutics Director · filings 2023 to 2023

DateTransactionSharesPriceValueHeld afterSource
Oct 26, 2023Grant or award from the company
Stock Option (right to buy)
+45,00045,000 directFiling · EDGAR

Jazz Pharmaceuticals President and COO · filings 2018 to 2023

DateTransactionSharesPriceValueHeld afterSource
Mar 5, 2023Shares withheld for tax or exercise price−5,426$142.78$775K55,014 directFiling · EDGAR
Mar 3, 2023Grant or award from the company+13,45660,440 directFiling · EDGAR
Dec 5, 2022Other acquisition or disposition (see the filing)−10,46546,984 directFiling · EDGAR
Mar 5, 2022Shares withheld for tax or exercise price−4,802$153.96$739K57,251 directFiling · EDGAR
Mar 3, 2022Grant or award from the company+13,50762,053 directFiling · EDGAR
Jan 3, 2022Shares withheld for tax or exercise price−1,624$131.01$213K48,546 directFiling · EDGAR
Mar 5, 2021Shares withheld for tax or exercise price−3,718$164.75$613K49,961 directFiling · EDGAR
Feb 25, 2021Grant or award from the company+11,69553,679 directFiling · EDGAR
Jan 4, 2021Shares withheld for tax or exercise price−1,607$160.40$258K41,984 directFiling · EDGAR
Mar 5, 2020Shares withheld for tax or exercise price−1,735$124.50$216K43,391 directFiling · EDGAR
Feb 27, 2020Grant or award from the company+16,00045,126 directFiling · EDGAR
Feb 27, 2020Grant or award from the company
Incentive Stock Option (right to buy)
+886886 directFiling · EDGAR
Feb 27, 2020Grant or award from the company
Non-Qualified Stock Option (right to buy)
+39,11439,114 directFiling · EDGAR
Jan 3, 2020Returned to the company−1,599$146.09$234K29,126 directFiling · EDGAR
Feb 28, 2019Grant or award from the company+14,00030,512 directFiling · EDGAR
Feb 28, 2019Grant or award from the company
Incentive Stock Option (right to buy)
+714714 directFiling · EDGAR
Feb 28, 2019Grant or award from the company
Non-Qualified Stock Option (right to buy)
+34,28634,286 directFiling · EDGAR
Jan 3, 2019Shares withheld for tax or exercise price−1,604$126.01$202K16,512 directFiling · EDGAR
Mar 1, 2018Grant or award from the company+18,00018,000 directFiling · EDGAR
Mar 1, 2018Grant or award from the company
Incentive Stock Option (right to buy)
+2,8402,840 directFiling · EDGAR
Mar 1, 2018Grant or award from the company
Non-Qualified Stock Option (right to buy)
+42,16042,160 directFiling · EDGAR

Sunesis Pharmaceuticals President and CEO · filings 2005 to 2017 · sold $84K · bought $162K

DateTransactionSharesPriceValueHeld afterSource
Feb 28, 2024Shares withheld for tax or exercise price−3,747$6.55$25K128,017 directFiling · EDGAR
Jul 10, 2017Returned to the company
Employee Stock Option (right to buy)
−4,3060 directFiling · EDGAR
Jul 10, 2017Returned to the company
Employee Stock Option (right to buy)
−18,3330 directFiling · EDGAR
Jul 10, 2017Returned to the company
Employee Stock Option (right to buy)
−118,4350 directFiling · EDGAR
Jul 10, 2017Returned to the company
Employee Stock Option (right to buy)
−70,8340 directFiling · EDGAR
Jul 10, 2017Returned to the company
Employee Stock Option (right to buy)
−50,0000 directFiling · EDGAR
Jul 10, 2017Returned to the company
Employee Stock Option (right to buy)
−50,0010 directFiling · EDGAR
Jul 10, 2017Returned to the company
Employee Stock Option (right to buy)
−50,0000 directFiling · EDGAR
Jul 10, 2017Grant or award from the company
Employee Stock Option (right to buy)
+17,58217,582 directFiling · EDGAR
Jul 10, 2017Grant or award from the company
Employee Stock Option(right to buy)
+240,177240,177 directFiling · EDGAR
Nov 30, 2016Grant or award from the company
Stock Option (Right to Buy)
+240,000240,000 directFiling · EDGAR
Feb 29, 2016Grant or award from the company+137,533322,194 directFiling · EDGAR
Feb 29, 2016Shares withheld for tax or exercise price−55,675$0.75$42K266,519 directFiling · EDGAR
Nov 30, 2015Grant or award from the company
Stock Option (Right to Buy)
+660,000660,000 directFiling · EDGAR
Aug 25, 2015Open-market or private purchase+12,216$1.01$12K199,736
See footnote.
Filing · EDGAR
Aug 24, 2015Open-market or private purchase+12,784$1.01$13K187,520
See footnote.
Filing · EDGAR
Jul 24, 2015In-the-money option exercised+22,210$1.32$29K151,346
See footnote
Filing · EDGAR
Jul 24, 2015Open-market or private sale−8,477$3.46$29K142,869
See footnote
Filing · EDGAR
Jul 24, 2015In-the-money option exercised+11,105$1.32$15K153,974
See footnote
Filing · EDGAR
Jul 24, 2015Open-market or private sale−4,238$3.46$15K149,736
See footnote
Filing · EDGAR
Jul 24, 2015Open-market or private purchase+25,000$1.02$25K174,336
See footnote
Filing · EDGAR
Jul 24, 2015In-the-money option exercised
Warrant (right to buy)
−22,2100
See footnote
Filing · EDGAR
Jul 24, 2015In-the-money option exercised
Warrant (right to buy)
−11,1050
See footnote
Filing · EDGAR
Feb 27, 2015Grant or award from the company+30,330188,098 directFiling · EDGAR
Feb 27, 2015Shares withheld for tax or exercise price−12,274$2.22$27K175,824 directFiling · EDGAR
Oct 31, 2014Grant or award from the company
Stock Option (Right to Buy)
+300,000300,000 directFiling · EDGAR
Aug 27, 2014Option or RSU exercised or converted+5,000$2.09$10K159,073 directFiling · EDGAR
Aug 27, 2014Sale under a 10b5-1 plan−5,000$8.00$40K154,073 directFiling · EDGAR
Aug 27, 2014Option or RSU exercised or converted
Stock Option (right to buy)
−5,000710,611 directFiling · EDGAR
May 16, 2014Option or RSU exercised or converted+24,389$2.09$51K152,406 directFiling · EDGAR
May 16, 2014Option or RSU exercised or converted
Stock Optioon (Right to Buy)
−24,389715,611 directFiling · EDGAR
Feb 28, 2014Grant or award from the company+9,971$6.55$65K131,764 directFiling · EDGAR
Feb 28, 2014Grant or award from the company
Stock Option Right to Buy
+300,000300,000 directFiling · EDGAR
Jun 18, 2013Option or RSU exercised or converted+15,000$2.94$44K112,093 directFiling · EDGAR
Jun 18, 2013Option or RSU exercised or converted+10,000$2.09$21K122,093 directFiling · EDGAR
Jun 18, 2013Option or RSU exercised or converted
Stock Option (Right to Buy)
−15,000110,000 directFiling · EDGAR
Jun 18, 2013Option or RSU exercised or converted
Stock Option (Right to Buy)
−10,000740,000 directFiling · EDGAR
Feb 28, 2013Grant or award from the company+20,785101,745 directFiling · EDGAR
Feb 28, 2013Shares withheld for tax or exercise price−7,623$5.22$40K94,122 directFiling · EDGAR
Feb 28, 2013Grant or award from the company
Stock Option (Right to Buy)
+300,000300,000 directFiling · EDGAR
Feb 29, 2012Grant or award from the company+55,14394,748 directFiling · EDGAR
Feb 29, 2012Shares withheld for tax or exercise price+20,226$1.74$35K74,522 directFiling · EDGAR
Feb 29, 2012Grant or award from the company
Stock Option (Right to Buy)
+425,000425,000 directFiling · EDGAR
Nov 28, 2011Open-market or private purchase+2,500$1.14$3K127,176
See footnotes
Filing · EDGAR
Nov 21, 2011Open-market or private purchase+2,100$1.18$2K45,616 directFiling · EDGAR
Jul 15, 2011Open-market or private purchase+5,000$1.99$10K43,516 directFiling · EDGAR
Jun 30, 2011Grant or award from the company
Stock Option (Right to Buy)
+750,000750,000 directFiling · EDGAR
Feb 28, 2011Grant or award from the company+36,16051,781 directFiling · EDGAR
Feb 28, 2011Shares withheld for tax or exercise price−13,263$2.10$28K38,518 directFiling · EDGAR
Jul 30, 2010Grant or award from the company+83,505124,358 directFiling · EDGAR
Jul 30, 2010Shares withheld for tax or exercise price−30,62993,729 directFiling · EDGAR
Jun 30, 2010Open-market or private purchase+476,487476,487
See Footnote
Filing · EDGAR
Jun 30, 2010Derivative converted+199,890676,377
See Footnote
Filing · EDGAR
Jun 30, 2010Derivative converted
Series A Preferred Stock
+19,9890
See Footnote
Filing · EDGAR
Oct 30, 2009Open-market or private purchase
Series A Preferred Stock
+6,663$2.20$15K19,989
See footnote
Filing · EDGAR
Oct 30, 2009Open-market or private purchase
Common Stock Purchase Warrant
+66,630$0.13$8K66,630
See footnote
Filing · EDGAR
Aug 31, 2009Grant or award from the company
Stock Option (Right to Buy)
+750,000750,000 directFiling · EDGAR
Apr 3, 2009Open-market or private purchase
Series A Preferred Stock
+13,326$2.20$29K13,326
See footnote
Filing · EDGAR
Apr 3, 2009Open-market or private purchase
Common Stock Purchase Warrant
+133,260133,260
See footnote
Filing · EDGAR
Sep 13, 2007Grant or award from the company
Employee Stock Option (right to buy)
+155,000155,000 directFiling · EDGAR

7 earlier transactions are in the filing list below.

All 148 Forms 3, 4, 5 and 144
FiledFormCompanyLinks
May 26, 2026Form 4Corcept Therapeutics CORTFiling · EDGAR
Oct 15, 2025Form 4Corcept Therapeutics CORTFiling · EDGAR
Oct 10, 2025Form 144Corcept Therapeutics CORTFiling · EDGAR
Sep 11, 2025Form 4Corcept Therapeutics CORTFiling · EDGAR
Sep 10, 2025Form 144Corcept Therapeutics CORTFiling · EDGAR
Aug 12, 2025Form 4Corcept Therapeutics CORTFiling · EDGAR
Aug 11, 2025Form 144Corcept Therapeutics CORTFiling · EDGAR
Jul 14, 2025Form 4Corcept Therapeutics CORTFiling · EDGAR
Jul 10, 2025Form 144Corcept Therapeutics CORTFiling · EDGAR
Jun 12, 2025Form 4Corcept Therapeutics CORTFiling · EDGAR
Jun 10, 2025Form 144Corcept Therapeutics CORTFiling · EDGAR
Jun 4, 2025Form 4Cerus CERSFiling · EDGAR
May 14, 2025Form 4Corcept Therapeutics CORTFiling · EDGAR
May 12, 2025Form 144Corcept Therapeutics CORTFiling · EDGAR
May 12, 2025Form 144Corcept Therapeutics CORTFiling · EDGAR
Apr 14, 2025Form 4Corcept Therapeutics CORTFiling · EDGAR
Apr 10, 2025Form 144Corcept Therapeutics CORTFiling · EDGAR
Mar 12, 2025Form 4Corcept Therapeutics CORTFiling · EDGAR
Mar 10, 2025Form 144Corcept Therapeutics CORTFiling · EDGAR
Feb 12, 2025Form 4Corcept Therapeutics CORTFiling · EDGAR
Feb 10, 2025Form 144Corcept Therapeutics CORTFiling · EDGAR
Jan 14, 2025Form 4Corcept Therapeutics CORTFiling · EDGAR
Jan 10, 2025Form 144Corcept Therapeutics CORTFiling · EDGAR
Dec 12, 2024Form 4Corcept Therapeutics CORTFiling · EDGAR
Dec 10, 2024Form 144Corcept Therapeutics CORTFiling · EDGAR
Nov 13, 2024Form 4Corcept Therapeutics CORTFiling · EDGAR
Nov 12, 2024Form 144Corcept Therapeutics CORTFiling · EDGAR
Aug 5, 2024Form 4Corcept Therapeutics CORTFiling · EDGAR
Aug 1, 2024Form 144Corcept Therapeutics CORTFiling · EDGAR
Jul 3, 2024Form 4Corcept Therapeutics CORTFiling · EDGAR
Jul 1, 2024Form 144Corcept Therapeutics CORTFiling · EDGAR
Jun 6, 2024Form 4Cerus CERSFiling · EDGAR
Jun 5, 2024Form 4Corcept Therapeutics CORTFiling · EDGAR
Jun 3, 2024Form 144Corcept Therapeutics CORTFiling · EDGAR
May 21, 2024Form 4Corcept Therapeutics CORTFiling · EDGAR
May 9, 2024Form 4Cerus CERSFiling · EDGAR
May 3, 2024Form 4Corcept Therapeutics CORTFiling · EDGAR
May 1, 2024Form 144Corcept Therapeutics CORTFiling · EDGAR
Apr 3, 2024Form 4Corcept Therapeutics CORTFiling · EDGAR
Apr 1, 2024Form 144Corcept Therapeutics CORTFiling · EDGAR
Mar 5, 2024Form 4Corcept Therapeutics CORTFiling · EDGAR
Mar 1, 2024Form 144Corcept Therapeutics CORTFiling · EDGAR
Feb 2, 2024Form 4Corcept Therapeutics CORTFiling · EDGAR
Feb 1, 2024Form 144Corcept Therapeutics CORTFiling · EDGAR
Jan 4, 2024Form 4Corcept Therapeutics CORTFiling · EDGAR
Jan 2, 2024Form 144Corcept Therapeutics CORTFiling · EDGAR
Dec 5, 2023Form 4Corcept Therapeutics CORTFiling · EDGAR
Dec 1, 2023Form 144Corcept Therapeutics CORTFiling · EDGAR
Nov 3, 2023Form 4Corcept Therapeutics CORTFiling · EDGAR
Nov 1, 2023Form 144Corcept Therapeutics CORTFiling · EDGAR
Oct 30, 2023Form 4Protagonist TherapeuticsFiling · EDGAR
Oct 30, 2023Form 3Protagonist TherapeuticsFiling · EDGAR
Oct 4, 2023Form 4Corcept Therapeutics CORTFiling · EDGAR
Oct 2, 2023Form 144Corcept Therapeutics CORTFiling · EDGAR
Sep 6, 2023Form 4Corcept Therapeutics CORTFiling · EDGAR
Sep 5, 2023Form 144Corcept Therapeutics CORTFiling · EDGAR
Sep 1, 2023Form 144Corcept Therapeutics CORTFiling · EDGAR
Aug 9, 2023Form 4Corcept Therapeutics CORTFiling · EDGAR
Aug 7, 2023Form 144Corcept Therapeutics CORTFiling · EDGAR
Jun 9, 2023Form 4Cerus CERSFiling · EDGAR
May 30, 2023Form 4Cerus CERSFiling · EDGAR
May 23, 2023Form 4Corcept Therapeutics CORTFiling · EDGAR
Mar 7, 2023Form 4Jazz PharmaceuticalsFiling · EDGAR
Dec 7, 2022Form 4Jazz PharmaceuticalsFiling · EDGAR
Nov 14, 2022Form 4Cerus CERSFiling · EDGAR
Aug 9, 2022Form 4Corcept Therapeutics CORTFiling · EDGAR
Jun 3, 2022Form 4Cerus CERSFiling · EDGAR
Jun 2, 2022Form 4Corcept Therapeutics CORTFiling · EDGAR
Mar 9, 2022Form 4Jazz PharmaceuticalsFiling · EDGAR
Jan 5, 2022Form 4Jazz PharmaceuticalsFiling · EDGAR
Sep 3, 2021Form 4Corcept Therapeutics CORTFiling · EDGAR
Aug 5, 2021Form 4Cerus CERSFiling · EDGAR
Jun 4, 2021Form 4Corcept Therapeutics CORTFiling · EDGAR
Jun 3, 2021Form 4Cerus CERSFiling · EDGAR
May 28, 2021Form 4Corcept Therapeutics CORTFiling · EDGAR
May 20, 2021Form 4Cerus CERSFiling · EDGAR
Apr 7, 2021Form 4Corcept Therapeutics CORTFiling · EDGAR
Mar 9, 2021Form 4Jazz PharmaceuticalsFiling · EDGAR
Mar 1, 2021Form 4Jazz PharmaceuticalsFiling · EDGAR
Feb 18, 2021Form 4Cerus CERSFiling · EDGAR
Jan 21, 2021Form 4Corcept Therapeutics CORTFiling · EDGAR
Jan 6, 2021Form 4Jazz PharmaceuticalsFiling · EDGAR
Nov 19, 2020Form 4Cerus CERSFiling · EDGAR
Oct 21, 2020Form 4Corcept Therapeutics CORTFiling · EDGAR
Jul 20, 2020Form 4Corcept Therapeutics CORTFiling · EDGAR
Jun 9, 2020Form 4Cerus CERSFiling · EDGAR
Jun 5, 2020Form 4Cerus CERSFiling · EDGAR
May 29, 2020Form 4Corcept Therapeutics CORTFiling · EDGAR
May 27, 2020Form 4Corcept Therapeutics CORTFiling · EDGAR
Mar 9, 2020Form 4Jazz PharmaceuticalsFiling · EDGAR
Mar 2, 2020Form 4Jazz PharmaceuticalsFiling · EDGAR
Feb 6, 2020Form 4Cerus CERSFiling · EDGAR
Feb 3, 2020Form 4Cerus CERSFiling · EDGAR
Jan 6, 2020Form 4Jazz PharmaceuticalsFiling · EDGAR
Jun 20, 2019Form 4Corcept Therapeutics CORTFiling · EDGAR
Jun 7, 2019Form 4Cerus CERSFiling · EDGAR
Jun 6, 2019Form 4Cerus CERSFiling · EDGAR
Mar 4, 2019Form 4Jazz PharmaceuticalsFiling · EDGAR
Jan 7, 2019Form 4Jazz PharmaceuticalsFiling · EDGAR
Aug 22, 2018Form 4Corcept Therapeutics CORTFiling · EDGAR
Jul 11, 2018Form 4/ACerus CERSFiling · EDGAR
Jun 22, 2018Form 4Cerus CERSFiling · EDGAR
Jun 5, 2018Form 4Cerus CERSFiling · EDGAR
Mar 5, 2018Form 4Jazz PharmaceuticalsFiling · EDGAR
Jan 9, 2018Form 3Jazz PharmaceuticalsFiling · EDGAR
Jul 12, 2017Form 4Sunesis PharmaceuticalsFiling · EDGAR
Jun 12, 2017Form 4Cerus CERSFiling · EDGAR
May 26, 2017Form 4Corcept Therapeutics CORTFiling · EDGAR
Dec 6, 2016Form 4/ASunesis PharmaceuticalsFiling · EDGAR
Dec 2, 2016Form 4Sunesis PharmaceuticalsFiling · EDGAR
Jul 22, 2016Form 4Corcept Therapeutics CORTFiling · EDGAR
Jun 10, 2016Form 4Cerus CERSFiling · EDGAR
Mar 2, 2016Form 4Sunesis PharmaceuticalsFiling · EDGAR
Dec 2, 2015Form 4Sunesis PharmaceuticalsFiling · EDGAR
Aug 26, 2015Form 4Sunesis PharmaceuticalsFiling · EDGAR
Jul 28, 2015Form 4Sunesis PharmaceuticalsFiling · EDGAR
Jun 22, 2015Form 4Corcept Therapeutics CORTFiling · EDGAR
Jun 22, 2015Form 3Corcept Therapeutics CORTFiling · EDGAR
Jun 12, 2015Form 4Cerus CERSFiling · EDGAR
Mar 2, 2015Form 4Sunesis PharmaceuticalsFiling · EDGAR
Nov 3, 2014Form 4Sunesis PharmaceuticalsFiling · EDGAR
Aug 29, 2014Form 4Sunesis PharmaceuticalsFiling · EDGAR
Jul 11, 2014Form 4Cerus CERSFiling · EDGAR
May 19, 2014Form 4Sunesis PharmaceuticalsFiling · EDGAR
Mar 4, 2014Form 4Sunesis PharmaceuticalsFiling · EDGAR
Jun 19, 2013Form 4Sunesis PharmaceuticalsFiling · EDGAR
Mar 1, 2013Form 4Sunesis PharmaceuticalsFiling · EDGAR
Jan 4, 2013Form 4Cerus CERSFiling · EDGAR
Mar 2, 2012Form 4Sunesis PharmaceuticalsFiling · EDGAR
Jan 6, 2012Form 4Cerus CERSFiling · EDGAR
Nov 30, 2011Form 4Sunesis PharmaceuticalsFiling · EDGAR
Nov 22, 2011Form 4Sunesis PharmaceuticalsFiling · EDGAR
Jul 18, 2011Form 4Sunesis PharmaceuticalsFiling · EDGAR
Jul 5, 2011Form 4Sunesis PharmaceuticalsFiling · EDGAR
Jun 28, 2011Form 4Cerus CERSFiling · EDGAR
Jun 28, 2011Form 3Cerus CERSFiling · EDGAR
Mar 2, 2011Form 4Sunesis PharmaceuticalsFiling · EDGAR
Aug 3, 2010Form 4Sunesis PharmaceuticalsFiling · EDGAR
Jul 1, 2010Form 4Sunesis PharmaceuticalsFiling · EDGAR
Nov 3, 2009Form 4Sunesis PharmaceuticalsFiling · EDGAR
Sep 2, 2009Form 4Sunesis PharmaceuticalsFiling · EDGAR
Apr 6, 2009Form 4Sunesis PharmaceuticalsFiling · EDGAR
Sep 14, 2007Form 4Sunesis PharmaceuticalsFiling · EDGAR
Mar 21, 2007Form 4Sunesis PharmaceuticalsFiling · EDGAR
Dec 15, 2006Form 4Sunesis PharmaceuticalsFiling · EDGAR
Oct 17, 2006Form 4Sunesis PharmaceuticalsFiling · EDGAR
Dec 1, 2005Form 4Sunesis PharmaceuticalsFiling · EDGAR
Sep 27, 2005Form 3Sunesis PharmaceuticalsFiling · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched . The filing on SEC.gov is the record.